GYKI 14166

Drug Profile

GYKI 14166

Latest Information Update: 02 Dec 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator IVAX Drug Research Institute
  • Developer IVAX Drug Research Institute; Nonindustrial source
  • Class Antithrombotics
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Thrombosis

Most Recent Events

  • 02 Dec 1998 No-Development-Reported for Thrombosis in Hungary (Unknown route)
  • 02 Dec 1998 No-Development-Reported for Thrombosis in USA (Unknown route)
  • 25 Jan 1995 Preclinical development for Thrombosis in Hungary (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top